Presenter: Mr. Dr. P. Beer
Philip is a Physician Scientist focussed on cancer genomics and targeted therapeutics. He trained as a clinical haematologist at the Imperial College Hospitals, London, where he developed specialist expertise in the laboratory diagnosis and treatment of haematological cancers. He was awarded a PhD by the University of Cambridge in 2009, based on work with Tony Green’s group investigating genotype-phenotype correlations and genomic mechanisms of disease progression in haematological cancers. Following a year as a Clinical Lecturer in Cambridge, Philip spent 4 years with the group of Connie Eaves at the BC Cancer Agency in Vancouver, where his research focussed on the development of cellular models to study how leukaemia is initiated and propagated in human blood cells. He subsequently spent 2 years leading the clinical/scientific team at 14M Genomics, a company founded by the Sanger Institute to develop methods for the interrogation of cancer genomics to inform individual patient’s clinical pathways.
|University:||Wellcome Trust Sanger Institute|
|Address:||Wellcome Trust Genome Campus|
|City:||Hinxton, Cambridge CB10 1SA|
|Fon:||+44 (0)1223 499976|